Skip to content

Main Navigation

DRA
  • ÄLY2022
  • EN
  • FI
  • Services
    • Services for Pharmaceutical Industry
    • Services for Health Technology
  • Careers
  • Company
  • What’s New
  • Contact us

Author: dra-updater

Posts by dra-updater

DRA Consulting is now PharmaLex Finland

Posted on 01.30.2023 (02.07.2023)

As we are merging with the global service provider PharmaLex, our name has been changed to PharmaLex Finland.

Posted in News

Biological medicines: how does their manufacturing process differ from traditional medicines?

Posted on 01.24.2023 (01.24.2023)

The differences in the manufacturing process and the nature of the active substance itself mean that biologicals differ from traditional medicines in many ways.

Posted in Blogs

EU Council to postpone the MDR deadlines

Posted on 12.13.2022 (12.20.2022)

The commission’s plan would not automatically apply an extended transitional period for all the medical devices, but the extension would be allowed on the condition that it is critical for the safety of the patients.

Posted in News

Our team of great colleagues has grown again

Posted on 12.12.2022 (12.19.2022)

We are proud to introduce our new team of experts

Posted in News

This Christmas we give gifts to the Baltic Sea

Posted on 12.08.2022 (12.12.2022)

With our Christmas donation, we support the activities of the John Nurminen Foundation to save the Baltic Sea and its heritage.

Posted in News

Crisis-tolerant security of medicine supply

Posted on 11.28.2022 (12.20.2022)

DRA Consulting has conducted an extensive preliminary report on the operating environment of the medicine supply chain, commissioned by the healthcare pool that operates under the National Emergency Supply Agency.

Posted in Blogs

New COVID‑19 vaccine swiftly launched to the market in tight timeline

Posted on 11.08.2022 (11.08.2022)

Company prepared the launch of vaccine in extremely tight timeline. They needed help to prepare linguistically and medically correct product information texts in extremely tight timeline.

Posted in Cases

Market Access Expert, Nordic Market Access team 

Posted on 10.27.2022 (11.11.2022)

Our Nordic Market Access team is growing, and we are looking for an additional team member to join us in Finland.

Posted in News

From an independent company to part of PharmaLex Group – how it all happened

Posted on 10.24.2022 (10.24.2022)

When a company reaches a certain size and a certain level of maturity, the investors and other industry operators start to show interest. That is what happened to us too.

Posted in Blogs

Our expert team grows

Posted on 09.15.2022 (09.19.2022)

DRA’s expert team grows even stronger. We are pleased to announce the addition of new top talents to our ranks.

Posted in News

Success in medicinal product dossier preparation for global markets

Posted on 09.08.2022 (11.08.2022)

When developing a new medicinal product, our client opted for a global approach: they wanted to access all the major markets, and to benefit from synergy, they decided to prepare the CMC documentation for the EU, FDA and Japan authorities simultaneously.

Posted in Cases

Use the promotion code DRA20 for the trainings organised by the Finnish Pharmaceutical Information Centre 

Posted on 08.22.2022 (10.24.2022)

In celebration of DRA’s 20th anniversary, we can now offer a 20 % discount on the regular price of the trainings to our clients and partners.

Posted in News

Our growth story continues – DRA Consulting to become part of the PharmaLex Group

Posted on 08.16.2022 (09.07.2022)

DRA and PharmaLex are merging to create a centre of pharma and Health Tech expertise with nearly 3,000 experts. The merger will bring synergies for the customers of both companies while helping to accelerate Nordic cooperation in the pharmaceutical market.

Posted in News

Press Release: PharmaLex expands Nordic footprint across key business units with DRA Consulting merger

Posted on 08.15.2022 (08.16.2022)

PharmaLex expands Nordic footprint across key business units with DRA Consulting merger

Posted in News

Cooperation will make the Nordic region an attractive pharmaceutical market

Posted on 08.11.2022 (09.19.2022)

In the global pharmaceutical market, the individual Nordic countries are very small. Together, they are much larger, but still relatively lightweight. This is certainly true if you look purely at sales volumes.

Posted in Blogs

A sneak peek to the future: ÄLY seminar puts the spotlight on finnish innovations and solutions for sustainable drug development

Posted on 06.02.2022 (08.01.2022)

In this year’s ÄLY seminar organised by DRA, the discussion turned around different future visions about green pharmacy, corporate social responsibility, the latest innovations in health technology and the possibilities that quantum technology can offer for drug development.

Posted in News

DADI webinar: What will happen at go-live

Posted on 06.01.2022 (08.01.2022)

The first web-based form to be released in the DADI project is a variations form for human medicinal products, and it is still expected to go live in October 2022.

Posted in News

There is strength in numbers – DRA crowdsources visioning of the future

Posted on 06.01.2022 (08.01.2022)

Last year, we engaged all of our 100-plus employees in the organisation’s strategy work and visioning the future. This way, we managed to harness the silent knowledge of all our employees for the company’s foresight process, and by crowdsourcing, we also future-proofed our strategy.

Posted in Blogs

Three new guidance documents related to IVD medical devices available

Posted on 05.31.2022 (08.01.2022)

Three guidance documents regarding in vitro diagnostic medical devices were published in May by the Medical Devices Coordination Group (MDCG).

Posted in News

New experts to join DRA – call for more talents still ongoing

Posted on 05.30.2022 (08.01.2022)

DRA keeps growing! Warmly welcome Virve and Maura.

Posted in News

Is it a drug or a device? A useful guidance document on borderline products available

Posted on 05.26.2022 (08.01.2022)

The Medical Device Coordination Group (MDCG) has provided guidance on how to better identify the borderline between a medical device and a drug.

Posted in News

One month till the new dawn – EU IVDR will be applied in full in May 2022

Posted on 05.01.2022 (08.01.2022)

In this blog post, our Health Tech Team Leader Tiina Riihimäki provides an overview of the latest developments and the foreseeable challenges in the process. Read her expert advice on how to prepare for this historic legislative change.

Posted in Blogs

DRA Driving Responsible Action

Posted on 04.28.2022 (08.01.2022)

What does responsibility mean to you? What would you set as your goal for social responsibility in 2022? These are some of the questions that all DRA’s employees were asked in the beginning of this year.

Posted in Blogs

DRA Consulting Oy
Pakkalankuja 7
01510 Vantaa, Finland


+358 9 825 64 200

Facebook LinkedIn Instagram Twitter RSS
Subscribe to the DRA newsletter »

Media »

© 2022 DRA Consulting Oy
Cookie Policy | Privacy Policy